US Broker Ratings

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Powerhouse with 30.88% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leading player in the healthcare diagnostics and research industry, stands as a compelling investment opportunity for those looking to capitalize on the burgeoning demand for..

Zimmer Biomet Holdings (ZBH) Stock Analysis: Potential 18% Upside in a Competitive Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a significant player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $17.26 billion, this Indiana-based..

West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 49.58% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a current market capitalization of $16.63..

Sanofi (SNY) Investor Outlook: A Strong Buy with 23.72% Potential Upside

Sanofi (SNY), a titan in the healthcare sector, particularly within the general drug manufacturing industry, is garnering attention from investors due to its promising growth potential and robust dividend yield...

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Play with a 41.55% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK), with a market capitalization of $7.73 billion, operates in the dynamic biotechnology industry within the healthcare sector. This late-stage biopharmaceutical company is at the frontier of..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 11.17% Upside in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, has been making waves with its innovative solutions for ophthalmic diseases. Headquartered in Aliso Viejo,..

Exact Sciences Corporation (EXAS) Stock Analysis: Steady Growth in Diagnostics Sector with 3.39% Potential Upside

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the diagnostics and research sector, has attracted significant investor attention as its current stock price hovers at $102.34, nearing the upper end..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 9.71% Potential Upside in the Healthcare Giant

AstraZeneca PLC (NASDAQ: AZN), a colossus in the global biopharmaceutical landscape, continues to captivate investors with its solid performance and strategic collaborations. With a market capitalization of $287.64 billion, AstraZeneca..

The Ensign Group, Inc. (ENSG) Stock Analysis: Robust Growth and a 21% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $9.94 billion, the company..

ResMed Inc. (RMD) Stock Analysis: A Strong Performer with 15% Upside Potential

ResMed Inc. (NYSE: RMD) is a major player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $37.7 billion, the company has..

Repligen Corporation (RGEN) Stock Analysis: Navigating a 27.80% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) is garnering significant attention in the healthcare sector, specifically within the medical instruments and supplies industry. The company, headquartered in Waltham, Massachusetts, focuses on developing and..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential Amidst Robust Revenue Surge in Medical Devices

TransMedics Group, Inc. (NASDAQ: TMDX), a leader in the medical devices sector, is capturing the interest of investors with its innovative approach to organ transplant therapy. With a market capitalization..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Tapping into a 43% Potential Upside in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. Based in San Francisco, this medical device company has carved out..

Exelixis, Inc. (EXEL) Stock Analysis: Insights on Growth Potential and Market Position

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its focus on developing innovative oncology treatments. With a market capitalization of $11.13 billion, Exelixis..

Alkermes plc (ALKS) Stock Analysis: Navigating a 29% Potential Upside in the Biopharmaceutical Sector

Alkermes plc (NASDAQ: ALKS) stands out as a noteworthy player in the healthcare arena, specializing in the development and commercialization of pharmaceutical products that address significant unmet medical needs. Headquartered..

Natera, Inc. (NTRA) Stock Analysis: Potential Growth Amidst Strong Analyst Confidence

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry, is drawing significant attention in the healthcare sector. With a market capitalization of $32.23 billion, the company..

Legend Biotech Corporation (LEGN): Investor Outlook with a 278% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is captivating the attention of investors, particularly those with an appetite for risk and a focus on the healthcare sector. With a potential upside of..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 32% Potential Upside and Strong Buy Ratings

Investors seeking promising opportunities in the biotech sector may find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) particularly intriguing, given its robust product lineup and attractive valuation metrics. With a current market..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring an 84% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is drawing investor attention with its compelling growth potential. Operating within the Medical Instruments & Supplies industry, this..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook on a Biotech Leader with 60% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a prominent player in the biotechnology sector, specializing in the development and commercialization of therapies for life-threatening rare diseases. Based in San Rafael, California,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds